Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 37Leiomyosarcoma 12Liposarcoma 10Sarcoma, Ewing 4Neoplasms 4Liposarcoma, Myxoid 4Sarcoma, Synovial 3Rhabdomyosarcoma 3Histiocytoma, Malignant Fibrous 3Sarcoma, Alveolar Soft Part 2Ovarian Neoplasms 2Osteosarcoma 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Ichthyosis, X-Linked 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Bone Neoplasms 2Wilms Tumor 1Solitary Fibrous Tumors 1Sarcoma, Endometrial Stromal 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Lung Neoplasms 1Leiomyosarcoma Uterus 1Hemangioendothelioma 1

Interventions

pembrolizumab 5Specimen Handling 5Nivolumab 5Cyclophosphamide 5Magnetic Resonance Spectroscopy 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Cisplatin 3sargramostim 2fludarabine 2cabozantinib 2aflibercept 2X-Rays 2Stem Cell Transplantation 2Sirolimus 2Paclitaxel 2Mesna 2Melphalan 2Irinotecan 2Ipilimumab 2Ifosfamide 2Fluorouracil 2Fluorodeoxyglucose F18 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Doxorubicin 2Cryosurgery 2Busulfan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Trabectedin × Sarcoma × Clear all
NCT01453283 2017-07-02

Tabectedin to Treat Children and Adolescents With Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
12 enrolled
CNSGastrointestinalGenitourinarySarcoma

Brain Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡